Quick Answer
Senti Biosciences Holdings, Inc. reported Total Assets of $51.22 million for the year ending 2025.
- Senti Biosciences Holdings, Inc. showed a decrease of -47.6% in Total Assets from 2024 to 2025.
- This data is from Senti Biosciences Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $373.7 thousand | Q2 2021: $231.89 million | Q3 2021: $231.66 million | Q1 2022: $230.92 million | Q2 2022: $202.36 million | Q3 2022: $189.44 million | Q1 2023: $161.43 million | Q2 2023: $143.63 million | Q3 2023: $131.77 million | Q1 2024: $102.19 million | Q2 2024: $86.91 million | Q3 2024: $57.72 million | Q1 2025: $82.78 million | Q2 2025: $68.54 million | Q3 2025: $52.69 million.
- Over the full 5 years of available data (2021 to 2025), Senti Biosciences Holdings, Inc.'s Total Assets has declined by 47.0%.
- Historical annual values: Fiscal year 2025: $51.22 million | Fiscal year 2024: $97.84 million | Fiscal year 2023: $119.48 million | Fiscal year 2022: $180.79 million | Fiscal year 2021: $96.70 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: